Edition:
United Kingdom

Phibro Animal Health Corp (PAHC.OQ)

PAHC.OQ on NASDAQ Stock Exchange Global Market

45.00USD
23 May 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$45.00
Open
$45.00
Day's High
$45.75
Day's Low
$44.70
Volume
25,042
Avg. Vol
35,136
52-wk High
$45.95
52-wk Low
$32.10

Latest Key Developments (Source: Significant Developments)

Phibro Animal Health Corp posts Q3 ‍adj. EPS $0.38​​
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Phibro Animal Health Corp :Phibro Animal Health Corp - qtrly ‍net sales of $193 million, an increase of $5 million, or 3 pct​.Phibro Animal Health Corp - qtrly ‍diluted EPS of $0.39​.Phibro Animal Health Corp - qtrly ‍adjusted diluted EPS of $0.38​.Q1 earnings per share view $0.37, revenue view $189.9 million -- Thomson Reuters I/B/E/S.Phibro Animal Health Corp - ‍reaffirmed financial guidance for fiscal year 2018 as initially presented in August 30, 2017 press release​.  Full Article

Phibro Q4 earnings per share $0.38
Monday, 29 Aug 2016 

Phibro Animal Health Corp : Q4 earnings per share $0.38 . Quarterly net sales of $189 million, an increase of 2 percent . Sees FY 2017 net sales of $750 million to $770 million . Sees FY 2017 adjusted diluted eps of $1.38 - $1.45 . Quarterly adjusted diluted EPS of $0.40 . Capital expenditures are expected to be about $30 million in FY 2017 . Expect operating margins to expand to about 15.5 percent for year 2017 . FY2017 revenue view $768.4 million -- Thomson Reuters I/B/E/S .Q4 earnings per share view $0.38, revenue view $183.6 million -- Thomson Reuters I/B/E/S.  Full Article

Phibro Animal Health submits studies reaffirming safety of Mecadox
Monday, 11 Jul 2016 

Phibro Animal Health Corp : Phibro animal health corporation submits studies reaffirming safety of Mecadox® .During studies no carcinogenic Carbadox-derived residues were detected in meat from animals treated, as directed, with Carbadox.  Full Article